ProstaCare UK Emblem
ProstaCare UK
Urological Health Institute
Medical Governance

Clinical Advisory Board & Editorial Governance

Ensuring rigorous medical accuracy, transparent conflict-of-interest disclosures, and evidence-based standards across all published male health resources.

Clinical advisory committee reviewing urological evidence
Our multi-disciplinary advisory panel meets quarterly in London to review emerging research on phytosterols and urological wellness.

Our Editorial Principles

ProstaCare UK adheres strictly to the principles of Evidence-Based Medicine (EBM). Health claims published on our site are substantiated by randomised, double-blind, placebo-controlled human clinical trials or systematic Cochrane reviews whenever possible.

Lead Advisors

Dr David Sterling Urologist

Dr. David Sterling, MBChB, FRCS (Urol)

Consultant Urological Surgeon • Lead Clinical Editor

Over 18 years of clinical experience within the NHS and independent urology practices in London and Cambridge. Author of 24 peer-reviewed publications on benign prostatic obstruction and minimally invasive therapies.

Dr Alistair Campbell Clinical Advisor

Dr. Alistair Campbell, BSc (Hons), PhD

Senior Research Fellow in Phytochemistry & Nutritional Biochemistry

Specialist in botanical lipid profiles and 5-alpha-reductase inhibition. Leads research evaluations on the standardisation of Serenoa repens and Curcubita pepo extracts.

Conflict of Interest Transparency

Our advisory panel operates under strict disclosure rules. Advisory reviews are conducted independently of commercial supplement manufacturers. Formulations discussed on our portal must comply fully with UK Food Standards Agency (FSA) regulations and MHRA non-medicinal borderlines.